Drug Co. Celladon Faces Stock Drop Suit After CEO's Exit
Pharmaceutical maker Celladon Corp. and two executives were sued in California federal court on Friday for allegedly misleading shareholders and boosting stock prices that plummeted after the CEO resigned and the...To view the full article, register now.
Already a subscriber? Click here to view full article